<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Teerikorpi N</submitter><funding>Sontag Foundation</funding><funding>Schmidt Futures</funding><funding>NIMH NIH HHS</funding><funding>Overlook Foundation</funding><funding>University of California, San Francisco</funding><funding>University of California</funding><funding>NINDS NIH HHS</funding><funding>William K. Bowes, Jr. Foundation</funding><funding>National Institutes of Health</funding><funding>NIH HHS</funding><funding>Esther A. and Joseph Klingenstein Fund</funding><pagination>dev204295</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12273630</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>152(12)</volume><pubmed_abstract>Autism spectrum disorder (ASD) and congenital heart disease (CHD) frequently co-occur, yet the underlying molecular mechanisms of this comorbidity remain unknown. Given that children with CHD are identified as newborns, understanding which CHD variants are associated with autism could help select individuals for early intervention. Autism gene perturbations commonly dysregulate neural progenitor cell (NPC) biology, so we hypothesized that CHD genes disrupting neurogenesis are more likely to increase ASD risk. Therefore, we performed an in vitro pooled CRISPR interference screen to identify CHD genes disrupting NPC biology and identified 45 CHD genes. A cluster of ASD and CHD genes are enriched for ciliary biology, and perturbing any one of seven such genes (CEP290, CHD4, KMT2E, NSD1, OFD1,</pubmed_abstract><journal>Development (Cambridge, England)</journal><pubmed_title>Ciliary biology intersects autism and congenital heart disease.</pubmed_title><pmcid>PMC12273630</pmcid><funding_grant_id>R01NS123263</funding_grant_id><funding_grant_id>R01 NS123263</funding_grant_id><funding_grant_id>R01MH125516</funding_grant_id><funding_grant_id>U01MH115747</funding_grant_id><funding_grant_id>U01 MH115747</funding_grant_id><funding_grant_id>12189</funding_grant_id><funding_grant_id>R01 MH125516</funding_grant_id><funding_grant_id>R01 MH128364</funding_grant_id><funding_grant_id>R01MH128364</funding_grant_id><pubmed_authors>Lasser MC</pubmed_authors><pubmed_authors>Nowakowski TJ</pubmed_authors><pubmed_authors>Bader E</pubmed_authors><pubmed_authors>Dea J</pubmed_authors><pubmed_authors>McCluskey KE</pubmed_authors><pubmed_authors>Sun N</pubmed_authors><pubmed_authors>Wang S</pubmed_authors><pubmed_authors>Nguyen CH</pubmed_authors><pubmed_authors>Teerikorpi N</pubmed_authors><pubmed_authors>Kostyanovskaya E</pubmed_authors><pubmed_authors>Schmidt JD</pubmed_authors><pubmed_authors>Willsey AJ</pubmed_authors><pubmed_authors>Willsey HR</pubmed_authors></additional><is_claimable>false</is_claimable><name>Ciliary biology intersects autism and congenital heart disease.</name><description>Autism spectrum disorder (ASD) and congenital heart disease (CHD) frequently co-occur, yet the underlying molecular mechanisms of this comorbidity remain unknown. Given that children with CHD are identified as newborns, understanding which CHD variants are associated with autism could help select individuals for early intervention. Autism gene perturbations commonly dysregulate neural progenitor cell (NPC) biology, so we hypothesized that CHD genes disrupting neurogenesis are more likely to increase ASD risk. Therefore, we performed an in vitro pooled CRISPR interference screen to identify CHD genes disrupting NPC biology and identified 45 CHD genes. A cluster of ASD and CHD genes are enriched for ciliary biology, and perturbing any one of seven such genes (CEP290, CHD4, KMT2E, NSD1, OFD1,</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jun</publication><modification>2026-03-18T13:55:56.226Z</modification><creation>2025-08-21T09:53:01.557Z</creation></dates><accession>S-EPMC12273630</accession><cross_references><pubmed>40552535</pubmed><doi>10.1242/dev.204295</doi></cross_references></HashMap>